Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-010329
Filing Date
2021-05-14
Accepted
2021-05-14 16:20:22
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20210331.htm   iXBRL 10-Q 1224131
2 EX-10.1 a2021q1exhibit101.htm EX-10.1 17689
3 EX-31.1 a2021q1exhibit311.htm EX-31.1 11763
4 EX-32.1 a2021q1exhibit321.htm EX-32.1 6030
  Complete submission text file 0001628280-21-010329.txt   5476590

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20210331.xsd EX-101.SCH 37408
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20210331_cal.xml EX-101.CAL 61296
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20210331_def.xml EX-101.DEF 197691
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20210331_lab.xml EX-101.LAB 483977
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20210331_pre.xml EX-101.PRE 326049
10 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20210331_htm.xml XML 781543
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 21924951
SIC: 2834 Pharmaceutical Preparations